Neuropsychiatric complications of HIV : a challenging health concern /
Neuropsychiatric Complications of HIV: A Challenging Health Concern examines these neuropsychiatric complications prevalent in those who are HIV positive, providing clinical correlation, translational significance, and details guides to neurocognitive assessment, brain imaging, and related neurophar...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
Academic Press,
[2025]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Intro
- Neuropsychiatric Complications of HIV: A Challenging Health Concern
- Copyright
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Acknowledgments
- Chapter 1: The neurobiology of human immunodeficiency virus infections
- Summary
- Introduction
- Clinical stages of HIV infection
- Group I: Primary HIV infection
- Group II: Asymptomatic phase
- Group III: Persistent generalized lymphadenopathy
- Group IV: Symptomatic HIV infection
- Molecular biology of the HIV virus
- Genetic diversity and HIV clades
- HIV replication
- NeuroAIDS
- Neurotoxicity and neuro-invasion
- Factors for NeuroAIDS
- Anti-retroviral drugs
- High-risk behavior
- Co-infection and co-morbidities
- Virus-related issues
- Host-related issues
- HIV latency and reservoir
- Conclusions
- Acknowledgments
- References
- Further reading
- Glossary
- Chapter 2: HIV-1-mediated neuropsychiatric complications: Diagnosis and management
- Summary
- HIV and its impact on global health
- HIV-1 infection and neuropsychiatric complications
- Mechanisms of HIV entry into the CNS
- The concept of viral reservoirs in the brain
- HIV-associated dementia
- Co-infections and development of neurophysiological disorders
- Methods for screening and diagnosis of HAND
- Anti-retroviral therapy-mediated neuropsychiatric toxicity
- Peripheral neuropathy
- Myopathy
- Lactic acidosis
- Discussion of diagnostic challenges and treatment decisions
- Diagnostic challenges
- Treatment decisions
- Mechanisms of pathogenesis
- Treatment optimization
- Precision medicine and personalized approaches
- Health disparities and social determinants
- Global perspectives and collaborative research
- Multi-disciplinary care and management
- Future directions and research
- Conclusion
- Acknowledgments
- References
- Glossary.
- Chapter 3: Neuropsychiatric complications among elderly people living with HIV
- Summary
- What you expect to know
- Introduction
- HIV and neuropathology
- HIV and psychoneuroimmunology
- Clinical spectrum of neuropsychiatric complications among elderly people living with HIV
- Classification and diagnosis of human immunodeficiency virus-associated neurocognitive disorder (HAND) phenotypes
- Immune reconstitution inflammatory syndrome in the nervous system (NeuroIRIS)
- NeuroAIDS
- Depressive spectrum disorder
- Mania
- Anxiety
- Psychotic disorders
- Late HIV diagnosis
- Treatment of neuropsychiatric complications among elderly patients with HIV
- Tricyclic anti-depressants
- Selective serotonin reuptake inhibitors
- Newer anti-depressant agents
- The way ahead
- Acknowledgment
- References
- Glossary
- Chapter 4: Epidemiology of neuropsychiatric complications in HIV
- Summary
- What you expect to know
- Introduction
- The multi-dimensional nexus of HIV and neuropsychiatric phenomena
- HIV and the brain: A molecular odyssey
- Genetic and environmental influences on cognitive risks in HIV
- Challenges and impact: Unmasking disparities in neuropsychiatric burden
- Unveiling gender disparities in HIV-related neuropsychiatric challenges
- Mechanisms and strategies: Paving the road to precision interventions
- Anti-retroviral therapy: A symphony of protection for cognitive function
- Unveiling prevalence: Charting cognitive landscapes in the context of HIV
- Navigating early shores: Early detection, strategic interventions, and beyond
- Epilogue: Fusing scientific insight with compassionate care
- Conclusion
- Questions
- References
- Further reading
- Glossary
- Chapter 5: Role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) genes in n
- Summary
- Introduction.
- HIV-related proteins
- Tropism of HIV infection
- HIV and neurotoxicity
- Pathogenesis of neuro-HIV
- Development of neuro-HIV
- Role of HIV-1 Tat protein in neurodegeneration
- Diagnosis of dementia
- HIV-associated dementia
- HIV-1-associated neurological dementia
- Genetic factors
- Matrix metalloproteinases
- Structure of MMPs
- Classification of MMPs
- Genetic variation in MMPs
- TIMPs
- The association between MMPs, TIMPs, and HAND
- Genetic variation in MMPs and TIMPs genes and HAND
- Therapy
- Forthcoming prospective
- Prospect suggestions
- Acknowledgment
- References
- Further readings
- Glossary
- Chapter 6: Genetics and epigenetics of NeuroAIDS
- Summary
- Introduction
- Genetic susceptibility to NeuroAIDS
- Immune-related genes
- CCR5 gene (C-C chemokine receptor type 5)
- Genes encoding monocyte chemoattractant protein-1 (MCP-1 or CCL2)
- CCL3 gene
- Apolipoprotein Epsilon 4 allele (APOE4)
- Dopamine-related genes
- NeuroAIDS epigenetic studies
- DNA methylation
- Histone modification
- miRNA regulation
- Role of iron-mediated mitochondrial dysmetabolism in neuroHIV/AIDS patients
- Genome-wide association studies (GWASs) in HAND
- HIV-associated neural tube defects in children
- WWW
- Conclusion and future perspective
- Acknowledgment
- References
- Further readings
- Glossary
- Chapter 7: Dementia and HIV infection
- Summary
- What you expect to know
- A brief history and current diagnostic nomenclature of HIV-associated neurocognitive disorder
- Clinical manifestations and cognitive profile of dementia
- Diagnosis of HAD
- Screening tests for HAD
- Extensive neuropsychological testing
- The role of comorbidities in HAD
- Diagnostic procedures and workup
- Differential diagnosis of HAD
- Treatment of HAD
- Conclusions
- Questions
- References
- Further reading.
- Chapter 8: BBB and neuroinflammation
- Summary
- Introduction
- BBB and its protective role
- BBB and its role in neuroinflammation
- Components of BBB
- Endothelial cells
- Pericytes
- Astrocytes
- Therapeutics in neuroinflammation
- Factors responsible for changing blood-brain barrier function: Development
- Nutrition
- Hypoxia
- Temperature
- Social and psychological stress
- Environmental pollution
- Effects of aging on blood-brain barrier
- Diseases and blood-brain barrier
- Alzheimer's disease and blood brain barrier
- Multiple sclerosis and blood-brain barrier
- Traumatic brain injury and blood-brain barrier
- Ischemic stroke and blood-brain barrier
- Conclusion
- Acknowledgment
- References
- Further reading
- Glossary
- Chapter 9: Neurological manifestations and neuropharmacology of HIV/AIDS
- Summary
- Introduction
- Neurological manifestation due to HIV
- HIV-associated neurocognitive disorder
- Neuropathogenesis of HAND
- Clinical features
- Aseptic meningitis
- Cerebrovascular disease
- Vacuolar myelopathy
- Peripheral neuropathy
- Myopathy
- Neuropharmacology of anti-retroviral drugs
- Neuropenetrance of anti-retroviral drugs
- CNS toxicity of ART
- NRTIs
- NNRTIs
- PIs
- INSTIs
- Entry inhibitors
- Recent advances
- Nano-ART
- Conclusion
- Essay-type questions
- Short answer questions
- World wide web resources
- References
- Glossary
- Chapter 10: Traumatic brain injury: An emerging threat for HIV-associated neurocognitive disorder
- Summary
- Introduction
- HIV-associated neurocognitive disorder
- HIV proteins, neuroinflammation, and HAND
- Aberrant neuronal signaling pathways associated with HAND
- Potential risk factors for HAND
- Traumatic brain injury as a potential co-morbidity in HIV patients and emerging risk factor for neurocognitive disorder.
- Mice models to study the impact of TBI and HIV infection to brain
- TBI models
- CCI model
- CHI model
- FPI model
- BI model
- Mice models for HIV infection in the brain
- Conclusion and future perspective
- Questions
- World wide web resources
- References
- Glossary
- Chapter 11: Drosophila as a model to study NeuroHIV: Insights from sleep function
- Summary
- Introduction
- Drosophila as model systems for HIV disease
- Strengths of Drosophila as a general research model
- Sleep disturbances and HIV infection
- Sleep in the Drosophila immune system and potential applications for NeuroHIV
- NEMURI linking sleep and immune function
- Tob signaling in sleep regulation and its potential role in immune system
- Draper signaling in sleep-related neuroprotection
- Limitations of using Drosophila as a model for NeuroHIV
- Conclusion
- Questions
- World wide web resources
- References
- Further reading
- Chapter 12: Human immunodeficiency virus and antibodies: Catch 22
- Summary
- Introduction
- Epitope accessibility by bnAbs
- Neutralization breadth predictors/parameters
- Broadly neutralizing antibodies from infants/children: A platform for potent neutralizers
- Elucidation of molecular pathways in attaining neutralization breadth
- HIV-1 broadly neutralizing antibodies in clinical development/trial
- A glimpse at the history of bnAb development and their clinical utility
- Ongoing clinical trials of bnAbs
- Why bnAb combinations are preferred over their individual administration?
- Antibody engineering: New hope for future as HIV therapeutics
- Conclusion
- Questions
- References
- Further reading
- Chapter 13: Elite neutralizers: An open eye for HIV vaccine development
- Summary
- Introduction
- Influence of viral diversification on bnAb selection.